Skip to content

A study to compare the effects of Chimaphila Umbellata 3x and individually selected homoeopathic medicines in people with enlarged prostate.

A double-armed prospective study to evaluate the effectiveness of Chimaphila Umbellata 3x compared to individualised homoeopathic medicine in Benign Prostatic Hyperplasia. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088035
Enrollment
36
Registered
2025-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Chimaphila Umbellata: Homoeopathic Medicine Chimaphilla Umbellata 3X mentioned in HPI will be administered orally according to principles of Homoeopathy for maximum 4 months. Control In

Sponsors

Dr Athira Soman
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria Male patients above or equal to 35 years of age satisfying case definition.

Exclusion criteria

Exclusion criteria: Homoeopathic Medicine Chimaphilla Umbellata 3X mentioned in HPI will be administered orally according to principles of Homoeopathy for maximum 4 months. 1. Benign Prostatic Hyperplasia with complications (retention of urine, hydroureter, hydronephrosis, hemorrhage). 2. Cases with a history of Prostate cancer, Bladder cancer. 3. Cases with serious systemic illnesses like renal failure, immunosuppression.

Design outcomes

Primary

MeasureTime frame
Utility of the treatment will be evaluated by changes in the International Prostate Symptom Score before and after treatment.Timepoint: The International Prostate Symptom Score will be assessed at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, 12 weeks, 14 weeks and 16 weeks.

Secondary

MeasureTime frame
Utility of treatment will be evaluated by changes in USG findings (prostate volume & post void residual urine volume) before & after homoeopathic treatment.Timepoint: USG will be assessed at baseline & at 16 weeks.

Countries

India

Contacts

Public ContactDr Nimimole K L

Government Homoeopathic Medical College Kozhikode

nimimolekl@yahoo.com8075888791

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026